UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
MAGELLAN HEALTH SERVICES, INC.
------------------------------
(Name of Issuer)
Common Stock, $0.25 par value
-----------------------------
(Title of Class of Securities)
559079108
---------
(CUSIP Number)
Murray A. Indick
BLUM Capital Partners, L.P.
(formerly Richard C. Blum & Associates, L.P.)
909 Montgomery Street, Suite 400
San Francisco, CA 94133
(415) 434-1111
--------------
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
January 27, 2000
----------------
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition which is the subject of this Schedule 13D, and is filing this
schedule because of Rule 13d-1(b)(3) or (4), check the following box [ ].
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities,
and for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be
deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 ("Act") or otherwise subject to the liabilities of that section of
the Act but shall be subject to all other provisions of the Act (however, see
the Notes).
Page 1 of 14
CUSIP NO. 559079108 SCHEDULE 13D Page 2 of 14
- ------------------------------------------------------------------------------
1. NAME OF REPORTING PERSON RCBA STRATEGIC PARTNERS, L.P.
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON 94-3303833
- ------------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [x]
(b) [x]
- ------------------------------------------------------------------------------
3. SEC USE ONLY
- ------------------------------------------------------------------------------
4. SOURCE OF FUNDS* WC
- ------------------------------------------------------------------------------
5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) or 2(e) [ ]
- ------------------------------------------------------------------------------
6. CITIZENSHIP OR PLACE OF ORGANIZATION Delaware
- ------------------------------------------------------------------------------
7. SOLE VOTING POWER -0-
NUMBER OF -----------------------------------------------------------
SHARES 8. SHARED VOTING POWER 3,165,500**
BENEFICIALLY
OWNED BY EACH -----------------------------------------------------------
PERSON WITH 9. SOLE DISPOSITIVE POWER -0-
-----------------------------------------------------------
10. SHARED DISPOSITIVE POWER 3,165,500**
- ------------------------------------------------------------------------------
11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 3,165,500**
- ------------------------------------------------------------------------------
12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES [ ]
- ------------------------------------------------------------------------------
13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 9.9%**
- ------------------------------------------------------------------------------
14. TYPE OF REPORTING PERSON PN
- ------------------------------------------------------------------------------
** See Item 5 below
*SEE INSTRUCTIONS BEFORE FILLING OUT!
CUSIP NO. 559079108 SCHEDULE 13D Page 3 of 14
- ------------------------------------------------------------------------------
1. NAME OF REPORTING PERSON RCBA GP, L.L.C.
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON 94-3303831
- ------------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [x]
(b) [x]
- ------------------------------------------------------------------------------
3. SEC USE ONLY
- ------------------------------------------------------------------------------
4. SOURCE OF FUNDS* See Item 3
- ------------------------------------------------------------------------------
5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) or 2(e) [ ]
- ------------------------------------------------------------------------------
6. CITIZENSHIP OR PLACE OF ORGANIZATION Delaware
- ------------------------------------------------------------------------------
7. SOLE VOTING POWER -0-
NUMBER OF -----------------------------------------------------------
SHARES 8. SHARED VOTING POWER 3,165,500**
BENEFICIALLY
OWNED BY EACH -----------------------------------------------------------
PERSON WITH 9. SOLE DISPOSITIVE POWER -0-
-----------------------------------------------------------
10. SHARED DISPOSITIVE POWER 3,165,500**
- ------------------------------------------------------------------------------
11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 3,165,500**
- ------------------------------------------------------------------------------
12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES [ ]
- ------------------------------------------------------------------------------
13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 9.9%**
- ------------------------------------------------------------------------------
14. TYPE OF REPORTING PERSON OO (Limited Liability Company)
- ------------------------------------------------------------------------------
** See Item 5 below
*SEE INSTRUCTIONS BEFORE FILLING OUT!
CUSIP NO. 559079108 SCHEDULE 13D Page 4 of 14
- -----------------------------------------------------------------------------
1. NAME OF REPORTING PERSON BLUM CAPITAL PARTNERS, L.P.
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON 94-3205364
- -----------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [x]
(b) [x]
- ------------------------------------------------------------------------------
3. SEC USE ONLY
- ------------------------------------------------------------------------------
4. SOURCE OF FUNDS* See Item 3
- ------------------------------------------------------------------------------
5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) or 2(e) [ ]
- ------------------------------------------------------------------------------
6. CITIZENSHIP OR PLACE OF ORGANIZATION California
- ------------------------------------------------------------------------------
7. SOLE VOTING POWER -0-
NUMBER OF -----------------------------------------------------------
SHARES 8. SHARED VOTING POWER 3,165,500**
BENEFICIALLY
OWNED BY EACH -----------------------------------------------------------
PERSON WITH 9. SOLE DISPOSITIVE POWER -0-
-----------------------------------------------------------
10. SHARED DISPOSITIVE POWER 3,165,500**
- ------------------------------------------------------------------------------
11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 3,165,500**
- ------------------------------------------------------------------------------
12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES [ ]
- ------------------------------------------------------------------------------
13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 9.9%**
- ------------------------------------------------------------------------------
14. TYPE OF REPORTING PERSON PN, IA
- ------------------------------------------------------------------------------
** See Item 5 below
*SEE INSTRUCTIONS BEFORE FILLING OUT!
CUSIP NO. 559079108 SCHEDULE 13D Page 5 of 14
- ------------------------------------------------------------------------------
1. NAME OF REPORTING PERSON RICHARD C. BLUM & ASSOCIATES, INC.
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON 94-2967812
- ------------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [x]
(b) [x]
- ------------------------------------------------------------------------------
3. SEC USE ONLY
- ------------------------------------------------------------------------------
4. SOURCE OF FUNDS* See Item 3
- ------------------------------------------------------------------------------
5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) or 2(e) [ ]
- ------------------------------------------------------------------------------
6. CITIZENSHIP OR PLACE OF ORGANIZATION California
- ------------------------------------------------------------------------------
7. SOLE VOTING POWER -0-
NUMBER OF -----------------------------------------------------------
SHARES 8. SHARED VOTING POWER 3,165,500**
BENEFICIALLY
OWNED BY EACH -----------------------------------------------------------
PERSON WITH 9. SOLE DISPOSITIVE POWER -0-
-----------------------------------------------------------
10. SHARED DISPOSITIVE POWER 3,165,500**
- ------------------------------------------------------------------------------
11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 3,165,500**
- ------------------------------------------------------------------------------
12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES [ ]
- ------------------------------------------------------------------------------
13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 9.9%**
- ------------------------------------------------------------------------------
14. TYPE OF REPORTING PERSON CO
- ------------------------------------------------------------------------------
** See Item 5 below
*SEE INSTRUCTIONS BEFORE FILLING OUT!
CUSIP NO. 559079108 SCHEDULE 13D Page 6 of 14
- ------------------------------------------------------------------------------
1. NAME OF REPORTING PERSON RICHARD C. BLUM
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
- ------------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [x]
(b) [x]
- ------------------------------------------------------------------------------
3. SEC USE ONLY
- ------------------------------------------------------------------------------
4. SOURCE OF FUNDS* See Item 3
- ------------------------------------------------------------------------------
5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) or 2(e) [ ]
- ------------------------------------------------------------------------------
6. CITIZENSHIP OR PLACE OF ORGANIZATION U.S.A.
- ------------------------------------------------------------------------------
7. SOLE VOTING POWER -0-
NUMBER OF -----------------------------------------------------------
SHARES 8. SHARED VOTING POWER 3,165,500**
BENEFICIALLY
OWNED BY EACH -----------------------------------------------------------
PERSON WITH 9. SOLE DISPOSITIVE POWER -0-
-----------------------------------------------------------
10. SHARED DISPOSITIVE POWER 3,165,500**
- ------------------------------------------------------------------------------
11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 3,165,500**
- ------------------------------------------------------------------------------
12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES [ ]
- ------------------------------------------------------------------------------
13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 9.9%**
- ------------------------------------------------------------------------------
14. TYPE OF REPORTING PERSON IN
- ------------------------------------------------------------------------------
** See Item 5 below
*SEE INSTRUCTIONS BEFORE FILLING OUT!
CUSIP NO. 559079108 SCHEDULE 13D Page 7 of 14
Item 1. Security and Issuer
- ----------------------------
This Schedule 13D relates to shares of Common Stock, $0.25 par value (the
"Common Stock") of Magellan Health Service, Inc., a Delaware corporation (the
"Issuer"). The principal executive office and mailing address of the Issuer is
6950 Columbia Gateway Drive, Suite 400, Columbia, Maryland 21046.
Item 2. Identity and Background
- --------------------------------
This Schedule 13D is being filed by RCBA Strategic Partners, L.P., a Delaware
limited partnership ("Strategic"); RCBA GP, L.L.C., a Delaware limited
liability company ("RCBA GP"); BLUM Capital Partners, L.P. (formerly Richard C.
Blum & Associates, L.P.), a California limited partnership ("BLUM LP"); Richard
C. Blum & Associates, Inc., a California corporation ("RCBA Inc."); and Richard
C. Blum, the Chairman and a substantial shareholder of RCBA Inc. and a managing
member of RCBA GP (collectively, the "Reporting Persons").
Strategic is a Delaware limited partnership whose principal business is
investing in securities and whose principal office is 909 Montgomery Street,
Suite 400, San Francisco, California 94133.
RCBA GP is a Delaware limited liability company whose principal business is
acting as the sole general partner of Strategic and whose principal office is
909 Montgomery Street, Suite 400, San Francisco, California 94133.
BLUM LP is a California limited partnership whose principal business is
acting as general partner for investment partnerships and providing investment
advisory services. BLUM LP is a registered investment adviser with the
Securities and Exchange Commission. The sole general partner of BLUM LP is
RCBA Inc.
The shares of Common Stock were acquired on behalf of BLUM LP's limited
partnerships and investment advisory client accounts and by Strategic.
The principal business office address of RCBA GP is 909 Montgomery Street,
Suite 400, San Francisco, CA 94133. The names of the managing members and
members of RCBA GP, their addresses, citizenship and principal occupations are
as follows:
Name and Business Citizen- Principal Occupation
Office Held Address ship or Employment
- -------------------- ----------------------- --------- --------------------
Richard C. Blum 909 Montgomery St. USA President & Chairman,
Managing Member Suite 400 BLUM LP
San Francisco, CA 94133
CUSIP NO. 559079108 SCHEDULE 13D Page 8 of 14
Name and Business Citizen- Principal Occupation
Office Held Address ship or Employment
- -------------------- ----------------------- --------- --------------------
Nils Colin Lind 909 Montgomery St. Norway Managing Partner,
Managing Member Suite 400 BLUM LP
San Francisco, CA 94133
Jeffrey W. Ubben 909 Montgomery St. USA Managing Partner,
Managing Member Suite 400 BLUM LP
San Francisco, CA 94133
George F. Hamel, Jr. 909 Montgomery St. USA Partner,
Member Suite 400 BLUM LP
San Francisco, CA 94133
Marc T. Scholvinck 909 Montgomery St. USA Partner and Chief
Member Suite 400 Financial Officer,
San Francisco, CA 94133 BLUM LP
Murray A. Indick 909 Montgomery St. USA Partner and
Member Suite 400 General Counsel,
San Francisco, CA 94133 BLUM LP
John C. Walker 909 Montgomery St. USA Partner,
Member Suite 400 BLUM LP
San Francisco, CA 94133
The principal business office address of BLUM LP and RCBA Inc. is 909
Montgomery Street, Suite 400, San Francisco, California 94133. The names of
the executive officers and directors of RCBA Inc., their addresses, citizenship
and principal occupations are as follows:
Name and Business Citizen- Principal Occupation
Office Held Address ship or Employment
- -------------------- ----------------------- --------- --------------------
Richard C. Blum 909 Montgomery St. USA President & Chairman,
President, Chairman Suite 400 BLUM LP
and Director San Francisco, CA 94133
Nils Colin Lind 909 Montgomery St. Norway Managing Partner,
Managing Partner Suite 400 BLUM LP
and Director San Francisco, CA 94133
Jeffrey W. Ubben 909 Montgomery St. USA Managing Partner,
Managing Partner Suite 400 BLUM LP
and Director San Francisco, CA 94133
CUSIP NO. 559079108 SCHEDULE 13D Page 9 of 14
Name and Business Citizen- Principal Occupation
Office Held Address ship or Employment
- -------------------- ----------------------- --------- --------------------
Claus J. Moller 909 Montgomery St. Denmark Managing Partner,
Managing Partner Suite 400 BLUM LP
and Director San Francisco, CA 94133
George F. Hamel, Jr. 909 Montgomery St. USA Partner,
Partner Suite 400 BLUM LP
San Francisco, CA 94133
Marc T. Scholvinck 909 Montgomery St. USA Partner and Chief
Partner, Chief Suite 400 Financial Officer,
Financial Officer, San Francisco, CA 94133 BLUM LP
Assistant Secretary
and Director
Murray A. Indick 909 Montgomery St. USA Partner and
Partner, General Suite 400 General Counsel,
Counsel & Secretary San Francisco, CA 94133 BLUM LP
John C. Walker 909 Montgomery St. USA Partner,
Partner Suite 400 BLUM LP
San Francisco, CA 94133
Kevin A. Richardson 909 Montgomery St. USA Partner,
Partner Suite 400 BLUM LP
San Francisco, CA 94133
To the best knowledge of the Reporting Persons, none of the entities or
persons identified in this Item 2 has, during the past five years, been
convicted of any criminal proceeding (excluding traffic violations or similar
misdemeanors), nor been a party to a civil proceeding of a judicial or
administrative body of competent jurisdiction and as a result of such
proceeding was or is subject to a judgment, decree or final order enjoining
future violations of, or prohibiting or mandating activities subject to,
federal or state securities laws or finding any violation with respect to such
laws.
Item 3. Source and Amount of Funds or Other Consideration
- ----------------------------------------------------------
The source of funds for the purchases of securities was the working capital of
Strategic and BLUM LP's limited partnerships and investment advisory client
accounts.
CUSIP NO. 559079108 SCHEDULE 13D Page 10 of 14
Item 4. Purpose of Transaction
- -------------------------------
The purpose of the acquisition of the Common Stock is for investment, and the
acquisitions of the Common Stock were made in the ordinary course of business
and were not made for the purpose of acquiring control of the Issuer.
Although no Reporting Person has any specific plan or proposal to acquire or
dispose of the Common Stock, consistent with its investment purpose, each
Reporting Person at any time and from time to time may acquire additional
Common Stock or dispose of any or all of its Common Stock depending upon an
ongoing evaluation of the investment in the Common Stock, prevailing market
conditions, other investment opportunities, liquidity requirements of the
Reporting Persons and/or other investment considerations.
Also, consistent with the investment purpose, the Reporting Persons may engage
in communications with one or more shareholders of the Issuer, one or more
officers of the Issuer and/or one or more members of the board of directors of
the Issuer and/or one or more representatives of the Issuer regarding the
Issuer, including but not limited to its operations. The Reporting Persons may
discuss ideas that, if effected may result in any of the following: the
acquisition by persons of additional Common Stock of the Issuer, an
extraordinary corporate transaction involving the Issuer, and/or changes in the
board of directors or management of the Issuer.
Except to the extent the foregoing may be deemed a plan or proposal, none of
the Reporting Persons has any plans or proposals which relate to, or could
result in, any of the matters referred to in paragraphs (a) through (j),
inclusive, of the instructions to Item 4 of Schedule 13D. The Reporting
Persons may, at any time and from time to time, review or reconsider their
position and/or change their purpose and/or formulate plans or proposals with
respect thereto.
Item 5. Interest in Securities of the Issuer
- ---------------------------------------------
(a),(b) According to the Issuer's most recent Form 10-K, there were 31,979,324
shares of Common Stock outstanding as of November 30, 1999. Based on such
information, after taking into account the transactions described in Item 5(c)
below, the Reporting Persons report the following direct holdings of the Common
Stock and corresponding percentage interest of total shares outstanding: (i)
Strategic reports direct holdings of 2,561,500 shares of the Common Stock
(8.0%); (ii) BLUM LP and RCBA Inc. report holdings of 542,400 shares of the
Common Stock (1.7%) owned directly by the limited partnerships for which BLUM
LP serves as the general partner and BLUM LP's investment advisory client
accounts; and (iii) Mr. Blum reports the aggregate of these shares for a total
of 3,103,900 shares of the Common Stock, which represents 9.7% of the
outstanding shares of the Common Stock.
In addition, because BLUM LP has voting and investment power with respect to
61,600 shares that are legally owned by The Common Fund for the account of its
CUSIP NO. 559079108 SCHEDULE 13D Page 11 of 14
Equity Fund ("The Common Fund"), those shares are reported as beneficially
owned by BLUM LP. The Common Fund is principally engaged in the business of
managing investments for educational institutions. The principal
administrative office of The Common Fund is located at 450 Post Road East,
Westport, Connecticut 06881-0909. The Common Fund disclaims membership in a
group with any of the Reporting Persons, and disclaims beneficial ownership of
any shares held by the Reporting Persons.
Voting and investment power concerning the above shares are held solely by
BLUM LP and RCBA GP. The Reporting Persons therefore may be deemed to be
members in a group, in which case each Reporting Person would be deemed to have
beneficial ownership of an aggregate of 3,165,500 shares of the Common
Stock, which is 9.9% of the outstanding shares of Common Stock. As the sole
general partner of BLUM LP, RCBA Inc. is deemed the beneficial owner of the
securities over which BLUM LP has voting and investment power. As Chairman,
director and a substantial shareholder of RCBA Inc., Richard C. Blum might be
deemed to be the beneficial owner of the securities beneficially owned by
RCBA Inc. Mr. Blum may also be deemed to be the beneficial owner of the
securities over which RCBA GP has voting and investment power. Although Mr.
Blum is joining in this Schedule as a Reporting Person, the filing of this
Schedule shall not be construed as an admission that he, or any of the other
shareholders, directors or executive officers of RCBA Inc., or managing
members and members of RCBA GP, is, for any purpose, the beneficial owner of
any of the securities that are beneficially owned by RCBA Inc. or RCBA GP,
except to the extent of any pecuniary interest therein.
(c) During the last 60 days, the Reporting Persons purchased the following
shares of Common Stock in the open market:
Entity Trade Date Shares Price/Share
- ------ ---------- ------- -----------
Strategic 01-27-00 2,319,300 7.1250
01-28-00 242,200 7.3750
BLUM LP's limited partnership 01-27-00 546,200 7.1250
and investment advisory client 01-28-00 57,800 7.3750
accounts (including The Common Fund)
(d) and (e) Not applicable.
CUSIP NO. 559079108 SCHEDULE 13D Page 12 of 14
Item 6. Contracts, Arrangements, Understandings or Relationships with Respect
to Securities of the Issuer
- ------------------------------------------------------------------------------
None of the Reporting Persons or, to the best knowledge of the Reporting
Persons, the other persons named in Item 2, is a party to any contract,
arrangement, understanding or relationship with respect to any securities of
the Issuer, including but not limited to the transfer or voting of any
securities of the Issuer, finder's fees, joint ventures, loan or option
arrangements, puts or calls, guarantees of profits, division of profits or
loss, or the giving or withholding of proxies, except (i) as previously
disclosed, or (ii) as noted above, BLUM LP has voting and investment power of
the shares held by it for the benefit of the Common Fund.
Item 7. Material to be Filed as Exhibits
- -----------------------------------------
Exhibit A Joint Filing Undertaking.
CUSIP NO. 559079108 SCHEDULE 13D Page 13 of 14
SIGNATURES
After reasonable inquiry and to the best of our knowledge and belief, the
undersigned certify that the information set forth in this statement is true,
complete and correct.
Dated: February 4, 2000
RCBA STRATEGIC PARTNERS, L.P. RCBA GP, L.L.C.
By RCBA GP, L.L.C.
its general partner
By /s/ Marc T. Scholvinck By /s/ Marc T. Scholvinck
------------------------------- -----------------------------------
Marc T. Scholvinck, Member Marc T. Scholvinck, Member
RICHARD C. BLUM & ASSOCIATES, INC. BLUM CAPITAL PARTNERS, L.P.
By Richard C. Blum & Associates, Inc.
its general partner
By /s/ Marc T. Scholvinck By /s/ Marc T. Scholvinck
------------------------------- -----------------------------------
Marc T. Scholvinck Marc T. Scholvinck
Partner, Chief Financial Officer Partner, Chief Financial Officer
and Assistant Secretary and Assistant Secretary
/s/ Marc T. Scholvinck
---------------------------------------
RICHARD C. BLUM
By Marc T. Scholvinck, Attorney-in-Fact
CUSIP NO. 559079108 SCHEDULE 13D Page 14 of 14
Exhibit A
JOINT FILING UNDERTAKING
The undersigned, being duly authorized thereunto, hereby execute this
agreement as an exhibit to this Schedule 13D to evidence the agreement of the
below-named parties, in accordance with the rules promulgated pursuant to the
Securities Exchange Act of 1934, to file this Schedule jointly on behalf of
each such party.
Dated: February 4, 2000
RCBA STRATEGIC PARTNERS, L.P. RCBA GP, L.L.C.
By RCBA GP, L.L.C.
its general partner
By /s/ Marc T. Scholvinck By /s/ Marc T. Scholvinck
------------------------------- -----------------------------------
Marc T. Scholvinck, Member Marc T. Scholvinck, Member
RICHARD C. BLUM & ASSOCIATES, INC. BLUM CAPITAL PARTNERS, L.P.
By Richard C. Blum & Associates, Inc.
its general partner
By /s/ Marc T. Scholvinck By /s/ Marc T. Scholvinck
------------------------------- -----------------------------------
Marc T. Scholvinck Marc T. Scholvinck
Partner, Chief Financial Officer Partner, Chief Financial Officer
and Assistant Secretary and Assistant Secretary
/s/ Marc T. Scholvinck
---------------------------------------
RICHARD C. BLUM
By Marc T. Scholvinck, Attorney-in-Fact
